• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Abbott India Ltd Pharmaceuticals - Multinational

  • MNC Asc-Abbott
  • BSE Code : 90.0
  • ISIN : INE358A01014
30,455.00 105 (0.35%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    30,130.00

  • Today’s High

    30,620.00

  • Open

    30,350.00

  • Perv Close

    30,350.00

  • 52W Low

    25,325.00

  • 52W High

    31,898.95

Key Indicators

  • P/E(TTM)

    45.75

  • Mar.Cap (₹Cr.)

    64,716.88

  • Div & Yield %

    1.56

  • Book Value(₹)

    1,992.07

  • Debt-Equity Ratio

    0.35

  • AGM Date

    30-May-2025

  • EPS

    665.62

  • P/E Ratio

    45.75

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    64,716.88

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.25

  • BV (₹)

    1,992.10

  • Sales( ₹ in Cr.)

    6,409.15

  • NP (in Cr.)

    1,414.44

  • NP Var(%)

    18.0

  • Div%

    4750.0

  • CPS (₹)

    699.40

  • EPS (₹)

    665.60

  • Traded Value (₹ in Lakhs)

    64,712.94

  • 52 Week High

    31,898.95

  • 52 Week Low

    25,325.00

  • Price BSE

    30453.0

  • Price NSE

    30,455.00

  • Market Capital( in Cr.)

    64,712.94

  • P/C Ratio

    43.50

  • P/E Ratio

    45.80

  • Price Vs.BV

    665.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 5,875.26 5,379.08 4,932.57 4,310.02 4,093.14 3,678.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 5,875.26 5,379.08 4,932.57 4,310.02 4,093.14 3,678.60
Other Income 248.27 154.15 83.16 80.90 114.39 113.29
Stock Adjustments -7.73 -66.09 22.28 104.00 -61.24 2.18
Total Income 6,115.80 5,467.14 5,038.01 4,494.92 4,146.29 3,794.07
EXPENDITURE :            
Raw Materials 3,212.88 2,908.97 2,679.49 2,494.92 2,254.39 2,090.78
Power and Fuel Cost 16.63 17.15 14.98 12.74 13.73 12.61
Employee Cost 576.58 563.59 579.46 492.65 476.11 435.58
Other Manufacturing Expenses 126.47 79.99 59.82 49.66 49.84 39.89
Selling and Administration Expenses 429.89 467.74 459.18 366.98 400.27 432.83
Miscellaneous Expenses 51.98 69.92 80.15 75.61 81.11 64.36
Employee Benefit Expenses 576.58 563.59 579.46 492.65 476.11 435.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,414.43 4,107.36 3,873.08 3,492.56 3,275.45 3,076.05
Operating Profit 1,701.37 1,359.78 1,164.93 1,002.36 870.84 718.03
Interest 12.45 15.99 19.10 18.28 8.53 2.25
Gross Profit 1,688.92 1,343.79 1,145.83 984.08 862.31 715.78
Depreciation 71.17 69.97 66.10 58.13 59.61 16.92
Profit Before Tax 1,617.75 1,273.82 1,079.73 925.95 802.70 698.86
Current Tax 415.46 325.60 281.16 239.05 208.29 245.87
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.07 -1.19 -0.13 -3.79 1.48 2.65
Reported Net Profit 1,201.22 949.41 798.70 690.69 592.93 450.33
Extraordinary Items 0.12 -0.19 0.00 -0.18 -0.41 6.18
Adjusted Net Profit 1,201.10 949.60 798.70 690.87 593.34 444.15
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -35.51 -24.02
P & L Balance brought forward 2,428.51 2,158.40 2,023.93 1,933.54 1,573.53 1,309.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 810.72 679.30 664.23 600.30 197.41 161.90
P & L Balance carried down 2,819.01 2,428.51 2,158.40 2,023.93 1,933.54 1,573.53
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 4,100.00 3,250.00 2,750.00 2,750.00 2,500.00 650.00
Dividend Per Share(Rs) 410.00 325.00 275.00 275.00 250.00 65.00
Earnings Per Share-Unit Curr 565.28 446.78 375.86 325.03 279.03 211.93
Earnings Per Share(Adj)-Unit Curr 565.28 446.78 375.86 325.03 279.03 211.93
Book Value 1,740.65 1,500.49 1,326.96 1,224.55 1,144.33 945.25
Book Value(Adj)-Unit Curr 1,740.65 1,500.49 1,326.96 1,224.55 1,144.33 945.25

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 15,934,048 74.99 15,934,048 3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 15,934,048 74.99 15,934,048 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,819 0.02 4,561 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 34,602 0.16 34,602 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 229,703 1.08 229,703 18
Mutual Funds / UTI 1,642,107 7.73 1,642,057 35
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 18,023 0.08 18,023 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,929,254 9.08 1,928,946 81
2] Non Institution
Bodies Corporate 145,823 0.69 145,733 981
Clearing Members 0 0.00 0 0
Directors of their Relatives 4 0.00 4 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 148,273 0.70 146,346 1,438
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 81,223 0.38 81,223 3
Individuals holding nominal share capital up to Rs. 1 lakh 2,820,793 13.27 2,651,892 65,808
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 189,884 0.89 189,884 1,619
Sub Total 3,386,000 15.93 3,215,082 69,850
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,249,302 100.00 21,078,076 69,934

Company Background

Abbott India LtdPharmaceuticals - Multinational

  • Abbott India Ltd
  • BSE Code : 90.0
  • ISIN : INE358A01014

  • Incorporation Year

    1944

  • Registered Office

    Unit No 3 Corporate Park
    Sion Trombay Road Chembur, Mumbai,
    Maharashtra-400071

  • Telephone

    91-22-67978888/50461000/2000/1119

  • FAX

    91-22-50169400

  • Chairman

    Munir Shaikh

  • Managing Director

    SWATI ROHAN DALAL

  • Company Secretary

  • Auditor

    S R B C & Co LLP/Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Abbott India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Novartis India 1,041.65 396.75 335.07 25.49 15.57
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92